BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kalashnikova E, Isupova E, Gaidar E, Lubimova N, Sorokina L, Chikova I, Kaneva M, Raupov R, Kalashnikova O, Aliev D, Gaydukova I, Kostik M. Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study. World J Nephrol 2024; 13(4): 98393 [PMID: 39723361 DOI: 10.5527/wjn.v13.i4.98393]
URL: https://www.wjgnet.com/2220-6124/full/v13/i4/98393.htm
Number Citing Articles
1
Valentina Natoli, Amandine Charras, Eve MD Smith, Christian M. Hedrich. Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and TreatmentCurrent Rheumatology Reports 2025; 27(1) doi: 10.1007/s11926-025-01207-7